These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 13331676)

  • 21. Lactic dehydrogenase versus glutamic oxalacetic acid transaminase as a diagnostic test for myocardial infarction.
    FREEMAN I; JACKSON DA; COLLIER CS
    Am J Med Sci; 1959 Jun; 237(6):768-70. PubMed ID: 13661165
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

  • 23. [ENZYME TESTS IN ROUTINE DIAGNOSIS. II. THE BEHAVIOR OF SERUM GLUTAMIC-OXALACETIC TRANSAMINASE (SGOT) AND SERUM LACTATE DEHYDROGENASE (SLDH) IN HEART INFARCT].
    SPODE E; SCHULTZ GW
    Arztl Forsch; 1965 Jun; 19():299-304. PubMed ID: 14309992
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute hepatic necrosis following iproniazid therapy; value of glutamic-oxaloacetic transaminase estimation in early detection.
    PARE CM; SANDLER M
    Lancet; 1959 Feb; 1(7067):282-4. PubMed ID: 13631997
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum transaminase: the diagnostic value of the estimation in cardiac infarction and liver damage.
    GUTTERIDGE NM; McKEAN CJ
    Med J Aust; 1958 Apr; 45(16):528-35. PubMed ID: 13540585
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic activator, glutamic oxaloacetic transaminase and potassium in myocardial tissue at various stages of human myocardial infarction.
    FISCHER S; ALBRECHTSEN OK; BANG NU
    Thromb Diath Haemorrh; 1959 Sep; 3():554-65. PubMed ID: 13823131
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum glutamic oxalacetic-transaminase activity in the diagnosis of myocardial infarction and hepatic necrosis.
    WALTERS MN; LITTLEJOHN PG
    Med J Aust; 1958 Jan; 45(3):76-80. PubMed ID: 13503423
    [No Abstract]   [Full Text] [Related]  

  • 28. The significance of alterations in serum glutamic oxaloacetic transaminase in experimental and clinical states.
    WROBLEWSKI F
    Trans N Y Acad Sci; 1956 Mar; 18(5):444-50. PubMed ID: 13312070
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum glutamic oxaloacetic transaminase elevation and possible hepatotoxicity accompanying the administration of ethionamide.
    PHILLIPS S; TREVATHAN RD
    Am Rev Respir Dis; 1962 Aug; 86():268-9. PubMed ID: 14486256
    [No Abstract]   [Full Text] [Related]  

  • 30. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. I. Serum transaminase activity in relation to the clinical picture.
    BIORCK G; HANSON A
    Acta Med Scand; 1956 Oct; 155(4):317-24. PubMed ID: 13361845
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with serum glutamic oxaloacetic transaminase.
    BERKMAN F; BHARGAVA AN
    Can Med Assoc J; 1959 Jun; 80(11):861-5. PubMed ID: 13662936
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous human serum glutamic oxalacetic transaminase; serum glutamic pyruvic transaminase and serum lactic dehydrogenase determinations.
    SENEVIRATNE KN; WATSON RS; PERERA SA
    Ceylon Med J; 1961 Jul; 6():7-11. PubMed ID: 13910663
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum glutamic oxalacetic transaminase in acute myocardial infarction.
    DEWAR HA; ROWELL NR; SMITH AJ
    Br Med J; 1958 Nov; 2(5105):1121-5. PubMed ID: 13584872
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the diagnostic significance of glutamic oxalacetic transaminase determination in the serum (Studies on its course in myocardial infarct)].
    RANIER O
    Wien Klin Wochenschr; 1959 Oct; 71():774-9. PubMed ID: 14436181
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum transaminase; a test to aid in diagnosis of cardiac infarction.
    DEUTSCH A
    Calif Med; 1956 Sep; 85(3):163-4. PubMed ID: 13356176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction.
    NYDICK I; RUEGSEGGER P; WROBLEWSKI F; LADUE JS
    Circulation; 1957 Mar; 15(3):324-34. PubMed ID: 13404705
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of serum glutamic oxalic acid transaminase in myocardial infarct].
    KERTESZ T; KREMMER T; ROTTER L; FERENCZY E
    Orv Hetil; 1960 Nov; 101():1596-9. PubMed ID: 13752709
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum glutamic oxaloacetic transaminase: a longitudinal study in infants.
    RUBIN SL
    Nebr State Med J; 1959 Sep; 44():458-9. PubMed ID: 14439900
    [No Abstract]   [Full Text] [Related]  

  • 39. Colorimetric measurement of serum glutamic oxaloacetic transaminase.
    CABAUD P; LEEPER R; WROBLEWSKI F
    Am J Clin Pathol; 1956 Sep; 26(9):1101-5. PubMed ID: 13362163
    [No Abstract]   [Full Text] [Related]  

  • 40. [On increase of glutamic-oxalic transaminase (SGPT) activity in myocardial infarction].
    RAFALOWICZ A
    Pol Tyg Lek; 1961 Oct; 16():1529-31. PubMed ID: 14489823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.